|
1
|
Almenawer SA, Farrokhyar F, Hong C,
Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B,
Reddy K, Murty N and Singh S: Chronic subdural hematoma management:
A systematic review and meta-analysis of 34,829 patients. Ann Surg.
259:449–457. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bartek J Jr, Sjåvik K, Dhawan S, Sagberg
LM, Kristiansson H, Ståhl F, Förander P, Chen CC and Jakola AS:
Clinical course in chronic subdural hematoma patients aged 18-49
compared to patients 50 years and above: A multicenter study and
meta-analysis. Front Neurol. 10(311)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ducruet AF, Grobelny BT, Zacharia BE,
Hickman ZL, DeRosa PL, Andersen KN, Sussman E, Carpenter A and
Connolly ES Jr: The surgical management of chronic subdural
hematoma. Neurosurg Rev. 35:155–169. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Henry J, Amoo M, Kissner M, Deane T,
Zilani G, Crockett MT and Javadpour M: Management of chronic
subdural hematoma: A systematic review and component network
meta-analysis of 455 studies with 103 645 cases. Neurosurgery.
91:842–855. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ostrom QT, Price M, Neff C, Cioffi G,
Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2016-2020. Neuro Oncol. 25 (12
Suppl 2):iv1–iv99. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Weller M, Wen PY, Chang SM, Dirven L, Lim
M, Monje M and Reifenberger G: Glioma. Nat Rev Dis Primers.
10(33)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang W and Huang J: Chronic subdural
hematoma: Epidemiology and natural history. Neurosurg Clin N Am.
28:205–210. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kotwica Z and Zawirski M: Subdural
hematoma caused by cerebral tumors. Zentralbl Neurochir.
47:259–262. 1986.PubMed/NCBI
|
|
11
|
Coombs JB, Coombs BL and Chin EJ: Acute
spontaneous subdural hematoma in a middle-aged adult: Case report
and review of the literature. J Emerg Med. 47:e63–e68.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pavlov V, Bernard G and Chibbaro S:
Chronic subdural haematoma management: An iatrogenic complication.
Case report and literature review. BMJ Case Rep.
2012(bcr1220115397)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Picca A, Berzero G, Di Stefano AL and
Sanson M: The clinical use of IDH1 and IDH2 mutations in gliomas.
Expert Rev Mol Diagn. 18:1041–1051. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ohgaki H and Kleihues P: The definition of
primary and secondary glioblastoma. Clin Cancer Res. 19:764–772.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Colman H, Zhang L, Sulman EP, McDonald JM,
Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross
JG, et al: A multigene predictor of outcome in glioblastoma. Neuro
Oncol. 12:49–57. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Tan PH, Ellis I, Allison K, Brogi E, Fox
SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The
2019 World Health Organization classification of tumours of the
breast. Histopathology. 77:181–185. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Olivier M, Hollstein M and Hainaut P: TP53
mutations in human cancers: Origins, consequences, and clinical
use. Cold Spring Harb Perspect Biol. 2(a001008)2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Watanabe K, Tachibana O, Sata K, Yonekawa
Y, Kleihues P and Ohgaki H: Overexpression of the EGF receptor and
p53 mutations are mutually exclusive in the evolution of primary
and secondary glioblastomas. Brain Pathol. 6:217–223.
1996.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cancer Genome Atlas Research Network. Brat
DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay
E, Miller CR, Vitucci M, et al: Comprehensive, integrative genomic
analysis of diffuse lower-grade gliomas. N Engl J Med.
372:2481–2498. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wiestler B, Capper D, Holland-Letz T,
Korshunov A, von Deimling A, Pfister SM, Platten M, Weller M and
Wick W: ATRX loss refines the classification of anaplastic gliomas
and identifies a subgroup of IDH mutant astrocytic tumors with
better prognosis. Acta Neuropathol. 126:443–451. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dummer R, Lebbé C, Atkinson V, Mandalà M,
Nathan PD, Arance A, Richtig E, Yamazaki N, Robert C, Schadendorf
D, et al: Combined PD-1, BRAF and MEK inhibition in advanced
BRAF-mutant melanoma: Safety run-in and biomarker cohorts of
COMBI-i. Nat Med. 26:1557–1563. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miao H, Choi BD, Suryadevara CM,
Sanchez-Perez L, Yang S, De Leon G, Sayour EJ, McLendon R, Herndon
JE II, Healy P, et al: EGFRvIII-specific chimeric antigen receptor
T cells migrate to and kill tumor deposits infiltrating the brain
parenchyma in an invasive xenograft model of glioblastoma. PLoS
One. 9(e94281)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Azimi P, Yazdanian T and Ahmadiani A: mRNA
markers for survival prediction in glioblastoma multiforme
patients: A systematic review with bioinformatic analyses. BMC
Cancer. 24(612)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rauhala M, Helén P, Huhtala H, Heikkilä P,
Iverson GL, Niskakangas T, Öhman J and Luoto TM: Chronic subdural
hematoma-incidence, complications, and financial impact. Acta
Neurochir (Wien). 162:2033–2043. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Iihara K, Saito N, Suzuki M, Date I, Fujii
Y, Houkin K, Inoue T, Iwama T, Kawamata T, Kim P, et al: The Japan
neurosurgical database: Statistics update 2018 and 2019. Neurol Med
Chir (Tokyo). 61:675–710. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen X, Huang W, Sun A, Wang L, Mo F and
Guo W: Bleeding risks with novel oral anticoagulants especially
rivaroxaban versus aspirin: A meta-analysis. Thromb J.
19(69)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Edlmann E, Giorgi-Coll S, Whitfield PC,
Carpenter K and Hutchinson PJ: Pathophysiology of chronic subdural
haematoma: Inflammation, angiogenesis and implications for
pharmacotherapy. J Neuroinflammation. 14(108)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jiang R, Wang NP, Tanaka KA, Levy JH,
Guyton RA, Zhao ZQ and Vinten-Johansen J: Factor Xa induces tissue
factor expression in endothelial cells by P44/42 MAPK and
NF-κB-dependent pathways. J Surg Res. 169:319–327. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Entezami P, Boulos A, Paul A,
Nourollahzadeh E and Dalfino J: Contrast enhancement of chronic
subdural hematomas after embolization of the middle meningeal
artery. Interv Neuroradiol. 25:596–600. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nordström CH: Letter to the editor: Rapid
selective brain cooling with PolarCap(®)-A commercial delusion. J
Neurotrauma. 40:1257–1258. 2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lepić M and Sato H: Editorial: Chronic
subdural hematoma (CSDH)-a well-known unknown. Front Neurol.
15(1461117)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jensen T, Olsen MH, Christoffersen C,
Binderup T and Fugleholm K: The cellular composition of chronic
subdural hematoma. Acta Neurochir (Wien). 166(208)2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Isaji T, Osuka K, Ohmichi Y, Ohmichi M,
Naito M, Nakano T, Iwami K and Miyachi S: Expression of
angiopoietins and angiogenic signaling pathway molecules in chronic
subdural hematomas. J Neurotrauma. 37:2493–2498. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Patel SA, Nilsson MB, Le X, Cascone T,
Jain RK and Heymach JV: Molecular mechanisms and future
implications of VEGF/VEGFR in cancer therapy. Clin Cancer Res.
29:30–39. 2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shen J, Zhang Y and Wu X: Rapamycin
promotes hematoma resorption and enhances endothelial cell function
by suppressing the mTOR/STAT3 signaling in chronic subdural
hematoma. Exp Cell Res. 433(113829)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Suzuki M, Endo S, Inada K, Kudo A,
Kitakami A, Kuroda K and Ogawa A: Inflammatory cytokines locally
elevated in chronic subdural haematoma. Acta Neurochir (Wien).
140:51–55. 1998.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Su GJ, Gao J, Wu CW, Zou JF, Zhang D, Zhu
DL, Liu J, Zhang JH and Huang XJ: Serum levels of MMP-8 and MMP-9
as markers in chronic subdural hematoma. J Clin Med.
11(902)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Galvão RP and Zong H: Inflammation and
gliomagenesis: Bi-Directional communication at early and late
stages of tumor progression. Curr Pathobiol Rep. 1:19–28.
2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bhat K, Balasubramaniyan V, Vaillant B,
Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L,
James JD, Goodman LD, et al: Mesenchymal differentiation mediated
by NF-κB promotes radiation resistance in glioblastoma. Cancer
Cell. 24:331–346. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Katz AM, Amankulor NM, Pitter K, Helmy K,
Squatrito M and Holland EC: Astrocyte-specific expression patterns
associated with the PDGF-induced glioma microenvironment. PLoS One.
7(e32453)2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Mega A, Nilsen MH, Leiss LW, Tobin NP,
Miletic H, Sleire L, Strell C, Nelander S, Krona C, Hägerstrand D,
et al: Astrocytes enhance glioblastoma growth. Glia. 68:316–327.
2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pripp AH and Stanišić M: The correlation
between pro- and anti-inflammatory cytokines in chronic subdural
hematoma patients assessed with factor analysis. PLoS One.
9(e90149)2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hyvärinen T, Hagman S, Ristola M, Sukki L,
Veijula K, Kreutzer J, Kallio P and Narkilahti S: Co-stimulation
with IL-1β and TNF-α induces an inflammatory reactive astrocyte
phenotype with neurosupportive characteristics in a human
pluripotent stem cell model system. Sci Rep.
9(16944)2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Raica M and Cimpean AM: Platelet-Derived
growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for
antitumor and antiangiogenic therapy. Pharmaceuticals (Basel).
3:572–599. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Chaudhary PK and Kim S and Kim S: An
insight into recent advances on platelet function in health and
disease. Int J Mol Sci. 23(6022)2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Xu X, Wang D, Han Z, Wang B, Gao W, Fan Y,
Li F, Zhou Z, Gao C, Xiong J, et al: A novel rat model of chronic
subdural hematoma: Induction of inflammation and angiogenesis in
the subdural space mimicking human-like features of progressively
expanding hematoma. Brain Res Bull. 172:108–119. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wajima D, Nakagawa I, Nakase H and
Yonezawa T: Neuroprotective effect of suppression of astrocytic
activation by arundic acid on brain injuries in rats with acute
subdural hematomas. Brain Res. 1519:127–135. 2013.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Asano T, Mori T, Shimoda T, Shinagawa R,
Satoh S, Yada N, Katsumata S, Matsuda S, Kagamiishi Y and Tateishi
N: Arundic acid (ONO-2506) ameliorates delayed ischemic brain
damage by preventing astrocytic overproduction of S100B. Curr Drug
Targets CNS Neurol Disord. 4:127–142. 2005.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Patabendige A, Singh A, Jenkins S, Sen J
and Chen R: Astrocyte activation in neurovascular damage and repair
following ischaemic stroke. Int J Mol Sci. 22(4280)2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Bianchi R, Giambanco I and Donato R:
S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1
Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.
Neurobiol Aging. 31:665–677. 2010.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Kumar M, Meode M, Blough M, Cairncross G
and Bose P: PDGF gene expression and p53 alterations contribute to
the biology of diffuse astrocytic gliomas. NPJ Genom Med.
8(6)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shaw SS, Schmidt AM, Banes AK, Wang X,
Stern DM and Marrero MB: S100B-RAGE-mediated augmentation of
angiotensin II-induced activation of JAK2 in vascular smooth muscle
cells is dependent on PLD2. Diabetes. 52:2381–2388. 2003.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Tyagi V, Theobald J, Barger J, Bustoros M,
Bayin NS, Modrek AS, Kader M, Anderer EG, Donahue B, Fatterpekar G
and Placantonakis DG: Traumatic brain injury and subsequent
glioblastoma development: Review of the literature and case
reports. Surg Neurol Int. 7(78)2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Sirko S, Schichor C, Della Vecchia P,
Metzger F, Sonsalla G, Simon T, Bürkle M, Kalpazidou S, Ninkovic J,
Masserdotti G, et al: Injury-specific factors in the cerebrospinal
fluid regulate astrocyte plasticity in the human brain. Nat Med.
29:3149–3161. 2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Michinaga S and Koyama Y:
Pathophysiological responses and roles of astrocytes in traumatic
brain injury. Int J Mol Sci. 22(6418)2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Munch TN, Gørtz S, Wohlfahrt J and Melbye
M: The long-term risk of malignant astrocytic tumors after
structural brain injury-a nationwide cohort study. Neuro Oncol.
17:718–724. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Laird MD, Vender JR and Dhandapani KM:
Opposing roles for reactive astrocytes following traumatic brain
injury. Neurosignals. 16:154–164. 2008.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Huse JT and Holland EC: Targeting brain
cancer: Advances in the molecular pathology of malignant glioma and
medulloblastoma. Nat Rev Cancer. 10:319–331. 2010.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Holl DC, Volovici V, Dirven C, Peul WC,
van Kooten F, Jellema K, van der Gaag NA, Miah IP, Kho KH, den
Hertog HM, et al: Pathophysiology and nonsurgical treatment of
chronic subdural hematoma: From past to present to future. World
Neurosurg. 116:402–411.e2. 2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Kim KH and Lee Y: Medical management of
chronic subdural hematoma. Korean J Neurotrauma. 19:288–297.
2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Georgountzos G, Gkalonakis I,
Anastasopoulos L, Stranjalis G and Kalamatianos T: Biofluid
biomarkers in the prognosis of chronic subdural hematoma: A
systematic scoping review. Diagnostics (Basel).
13(2449)2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Bergers G, Brekken R, McMahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and
Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic
switch during carcinogenesis. Nat Cell Biol. 2:737–744.
2000.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Su GJ, Zhang D, Wu JN, Deng YH, Wu CW,
Zhang XJ and Huang XJ: Immunoexpression of MMP-8 and MMP-9 in
chronic subdural hematoma. Front Neurol. 13(988854)2022.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Saleem M, Kweon MH, Johnson JJ, Adhami VM,
Elcheva I, Khan N, Hafeez BB, Bhat KM, Sarfaraz S, Reagan-Shaw S,
et al: S100A4 accelerates tumorigenesis and invasion of human
prostate cancer through the transcriptional regulation of matrix
metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830.
2006.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Zha C, Meng X, Li L, Mi S, Qian D, Li Z,
Wu P, Hu S, Zhao S, Cai J and Liu Y: Neutrophil extracellular traps
mediate the crosstalk between glioma progression and the tumor
microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biol Med.
17:154–168. 2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Wang M, Lv X, Wang Y, Li Y, Li H, Shen Z
and Zhao L: Biomarkers of peripheral blood neutrophil extracellular
traps in the diagnosis and progression of malignant tumors. Cancer
Med. 13(e6935)2024.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Nozawa H, Chiu C and Hanahan D:
Infiltrating neutrophils mediate the initial angiogenic switch in a
mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA.
103:12493–12498. 2006.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhang S, Guo M, Liu Q, Liu J and Cui Y:
Neutrophil extracellular traps induce a hypercoagulable state in
glioma. Immun Inflamm Dis. 9:1383–1393. 2021.PubMed/NCBI View Article : Google Scholar
|
